Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut J F Salzer

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Wiener Klinische Wochenschrift|August 29, 2022
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)Eva Rath, Michael Bonelli, Christina Duftner, et al.
Zeitschrift Fur Rheumatologie|November 7, 2022
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]Eva Rath, Michael Bonelli, Christina Duftner, et al.
Journal of Travel Medicine|August 8, 2018
Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017Helmut J F Salzer, Rhett J Stoney, Kristina M Angelo, et al.
ERJ Open Research|January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment optionsStefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.
Respiration; International Review of Thoracic Diseases|May 29, 2024
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and SwitzerlandRalf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2022
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, et al.
Plos One|May 21, 2016
Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU PatientsRobert Krause, Bettina Halwachs, Gerhard G Thallinger, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Critical Care (London, England)|March 27, 2026
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature reviewSarah Sedik, Daniel Felber, Peter Schellongowski, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Wiener Klinische Wochenschrift|August 29, 2022
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)Eva Rath, Michael Bonelli, Christina Duftner, et al.
Zeitschrift Fur Rheumatologie|November 7, 2022
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]Eva Rath, Michael Bonelli, Christina Duftner, et al.
Journal of Travel Medicine|August 8, 2018
Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017Helmut J F Salzer, Rhett J Stoney, Kristina M Angelo, et al.
ERJ Open Research|January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment optionsStefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.
Respiration; International Review of Thoracic Diseases|May 29, 2024
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and SwitzerlandRalf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2022
[Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, et al.
Plos One|May 21, 2016
Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU PatientsRobert Krause, Bettina Halwachs, Gerhard G Thallinger, et al.
Pneumologie (Stuttgart, Germany)|November 6, 2023
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, et al.
Critical Care (London, England)|March 27, 2026
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature reviewSarah Sedik, Daniel Felber, Peter Schellongowski, et al.
Pageof 10